NDA 018866 describes BETAMETHASONE VALERATE, which is a drug marketed by
Alembic,
Novast Labs,
Padagis Israel,
Taro,
Xiromed,
Fougera Pharms Inc,
Perrigo New York,
Pharmaderm,
Pharmafair,
Sciegen Pharms Inc,
Teva Pharms, and
Actavis Mid Atlantic, and is included in twenty NDAs. It is available from
ten suppliers. Additional details are available on the
BETAMETHASONE VALERATE profile page.
The generic ingredient in BETAMETHASONE VALERATE is
betamethasone valerate. There are sixty-six
drug master file entries for this compound. Fourteen
suppliers are listed for this compound. Additional details are available on the
betamethasone valerate profile page.